Privia Health Group, Inc.
NASDAQ:PRVA
23.75 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 1,736.39 | 1,657.737 | 1,356.66 | 966.22 | 817.075 | 786.36 | 657.609 |
| Kosten van de omzet
| 1,559.537 | 1,496.236 | 1,221.878 | 902.558 | 734.493 | 717.888 | 601.15 |
| Brutowinst
| 176.853 | 161.501 | 134.782 | 63.662 | 82.582 | 68.472 | 56.459 |
| Brutowinstmarge
| 0.102 | 0.097 | 0.099 | 0.066 | 0.101 | 0.087 | 0.086 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 126.157 | 109.587 | 129.592 | 255.884 | 44.016 | 41.827 | 41.497 |
| Verkoop- en marketingkosten
| 26.446 | 24.732 | 19.741 | 22.75 | 11.343 | 9.156 | 11.737 |
| Verkoop-, algemene en administratieve kosten
| 152.603 | 134.319 | 149.333 | 278.634 | 55.359 | 50.983 | 53.234 |
| Overige kosten
| 7.268 | 6.533 | 4.571 | 2.464 | 1.843 | 1.427 | 1.07 |
| Bedrijfskosten
| 159.871 | 140.852 | 153.904 | 281.098 | 57.202 | 52.41 | 54.304 |
| Bedrijfsresultaat
| 16.982 | 20.649 | -19.122 | -217.436 | 25.38 | 16.062 | 2.155 |
| Bedrijfsresultaat ratio
| 0.01 | 0.012 | -0.014 | -0.225 | 0.031 | 0.02 | 0.003 |
| Totaal overige inkomsten en kosten netto
| 10.888 | 8.372 | 0.542 | -1.07 | -1.917 | -6.91 | -6.42 |
| Inkomen voor belasting
| 27.87 | 29.021 | -18.58 | -218.506 | 23.463 | 9.152 | -4.265 |
| Inkomen voor belasting ratio
| 0.016 | 0.018 | -0.014 | -0.226 | 0.029 | 0.012 | -0.006 |
| Belastingkosten
| 10.826 | 7.993 | -6.516 | -27.857 | -7.441 | 1.207 | -0.076 |
| Nettowinst
| 14.385 | 23.079 | -12.064 | -190.649 | 31.244 | 8.244 | -3.044 |
| Nettowinstmarge
| 0.008 | 0.014 | -0.009 | -0.197 | 0.038 | 0.01 | -0.005 |
| WPA (Winst Per Aandeel)
| 0.12 | 0.2 | -0.11 | -1.77 | 0.3 | 0.078 | -0.03 |
| Verwaterde WPA
| 0.11 | 0.19 | -0.11 | -1.77 | 0.3 | 0.078 | -0.03 |
| EBITDA
| 24.25 | 27.182 | -14.551 | -214.972 | 27.223 | 17.489 | 3.227 |
| EBITDA ratio
| 0.014 | 0.016 | -0.011 | -0.222 | 0.033 | 0.022 | 0.005 |